Press Release from IDEC Pharmaceuticals, Inc. (Apr. 20, 2000). |
Press Release from IDEC Pharmaceuticals, Inc. (Jan. 29, 2001). |
Press Release from Biogen website (www.prnewswire.com), “Biogen Says it Has Halted Several Trials of Anti-CD40 Ligand Monoclonal Antibody”, Oct. 21, 1999. |
Press Release from Biogen website (www.prnewswire.com), “Biogen Says it Has Stopped Ongoing Trials of Anti-CD40 Ligand Monoclonal Antibody”, Nov. 2, 1999. |
Bajorath J. et al. “Identification of Residues on CD40 and Its Ligand Which Are Critical for the Receptor-Ligand Interaction”, Biochemistry 34:1833-1844 (1995). |
Banchereau J. et al. “The CD40 Antigen and its Ligand”, Annual Rev. Immunol. 12:881-922 (1994). |
Cleary, A. M. et al. “Opposing roles of CD95 (Fas/APO-1) and CD40 in the Death and Rescue of Human Low Density Tonsillar B Cells”, J. Immunol. 155:3329-3337 (1995). |
Fanslow W. C. et al. “Soluble Forms of CD40 Inhibit Biologic Responses of Human B Cells”, J. Immunol. 149:655-660 (1992). |
Yellin M. J. et al. “In situ Characterization of CD40L and CD40 Expression in Glomerulonephritis (GN)”, Abstract—ASBMB/ASIP/AAI Joint Meeting (1996). |
Yellin M. J. et al. “Function of CD40 Molecules Expressed on Cultured Synovial Membrane Fibroblasts”, FASEB J. 9:A774—Abstract No. 4483 (1995). |
Alderson, M.R. et al. (1993). J. Exp. Med. 178: 669-674. |
Carbone, A et al., (1995) Blood 85(3): 780-789. |
Clark, E A et al., (1986) Proc. Natl. Acad. Sci. USA 83: 4494-4498. |
Freudenthal, PS et al., (1990) Proc. Natl. Acad. Sci. USA 87: 7698-7702. |
Galy, AHM et al., (1992) J. Immunol. 149: 775-782. |
Hasbold, J et al., (1994) Eur. J. Immunol. 24: 1835-1842. |
Hollenbaugh, D et al., (1995) J. Exp. Med. 182: 33-40. |
Karmann, K et al., (1995) Proc. Natl. Acad. Sci. USA 92: 4342-4346. |
Karpusas, M et al., (1995) Structure 3(10): 1031-1039. |
Law, CL et al., (1990) Leukemia 4(11): 732-738. |
O'Grady, J T et al., (1994) Am. J. Pathology 144(1): 2126. |
Paulie, S et al., (1985) Cancer Immunol. Immunother. 20: 23-28. |
Potocnik, AJ et al., (1990) Scand. J. Immunol. 31: 213-224. |
Uckun, FM et al., (1990) Blood 76(12); 2449-2456. |
Urashima, M et al., (1995) Blood 85: 1903-1912. |
Valent, P et al., (1990) Int. Arch. Allergy Appl. Immunol. 91: 198-203. |
Westendorf, JJ et al., (1995) Curr. Top. Microbiol. Immunol. 194: 63-72. |
Westendorf JJ et al., (1994) J. Immunol. 152: 117-128. |
Yellin, M.J. et al., (1995) Oral Presentation at FASEB Meeting in Atlanta, GA, Apr. 12, 1995. |
Yellin, M.J. et al., (1995) Poster session at 9th International Congress of Immunology Meeting in San Francisco, CA. |
Yellin, M.J. et al., (1995) J. Leukocyte Biology 58: 209-216. |
Yellin, M.J. et al., (1995) J. Exp. Med. 182: 1857-1864. |
Young L.S. et al., (1989) Int. J. Cancer 43: 786-794. |
Kuntz Science 257: 1078-1082 (1992.* |
Buhlmann et al. J Clin Immunol. 16:83-89 (1996).* |
Larsen et al. Transplantation 61:4-9(1996).* |
Gray et al. J Exp Med. 180: 141-155(1994).* |
Stuber et al. J Exp Med. 183:693-698(1996).* |
Merck Manual 16th Ed. Merck Research Laboratories Rathway NJ 1992 p. 718.* |
Mohan et al. J. Immunol. J. Immunol 154:1470-1480(1995).* |
Laman et al. J. Neuroimmunol. 54:175 (1994).* |
Biacone et al. Kidney Intl. 48:458-468 (1995).* |
Durie et al. Res. Immunol. 145: 200-205 (1994).* |
Durie et al. Immunol. Today 15:406-411 (1994).* |
Lederman et al. Res. Immunol. 145:215-222(1994).* |
Durie et al. Science 261:1328-1330 (1993).* |
Kuwana et al. J. Immunol. 155: 2703-2714 (1995).* |
Haug et al. Transplantation 55:766-773 (1993).* |
Morgan et al. Transplantation 55:919-923 (1993).* |
Bancherean et al. Annu. Rev. Immunol. 12:881-922 (1994). |